Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Teleconference: Future of Gaucher Disease Therapies (11:00 AM EST / 15:00 GMT)

Time & Location

Originally Presented: October 27, 2009 11:00 AM

Presenter(s):

GLG Expert Contributor

Agenda:

  • Reaction to recently announced top-line data for Protalix BioTerapeutics’s Uplyso
  • Impact of Cerezyme supply shortage on use of other Gaucher Disease therapies
  • Adoption of velaglucerase, Uplyso and other novel therapies and its impact on Cerezyme use A transcript of this teleconference will be made available for purchase approximately 72 hours after the live call. To request a transcript, please click here.

Learn More About GLG Live Meetings

About GLG Live Meetings

A program focused on educating business and investment professionals through seminars on current trends and core concepts in various industries. Detailed workbooks distributed at the Seminars provide educational reference materials for later review. GLG Live Meetings enable clients to increase thier own industry education by proposing new seminar topics or adding agenda terms to currently scheduled seminars.